Adenosine 5’-monophosphate (AMP) activated protein kinase (AMPK) is a highly conserved sensor of cellular
energy. AMPK has been recognized as a key regulator of mammalian metabolic function and has emerged as an attractive
target for the treatment of metabolic disorders, including obesity and type 2 diabetes. The synthesis and biological evaluation
of novel 3-(4-oxothieno[2,3-d]pyrimidin-3(4H)-yl)propanoic acid derivatives as AMPK activators are described. The
in vivo proof of principle for plasma glucose lowering effect is exemplified with a lead compound from this series.
腺苷5'-单
磷酸(
AMP)激活的蛋白激酶(
AMPK)是一种高度保守的细胞能量感应器。
AMPK已被确认为调节哺乳动物代谢功能的关键因子,并已成为治疗包括肥胖和2型糖尿病在内的代谢紊乱的理想靶点。本文描述了新型3-(4-氧代
噻吩并[2,3-d]
嘧啶-3(4H)-基)
丙酸衍
生物作为
AMPK激活剂的合成和
生物学评价。体内实验证明了本系列中的先导化合物具有降低血浆
葡萄糖水平的原理验证作用。